We are analyzing https://link.springer.com/article/10.1007/s00415-012-6692-2.

Title:
Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica | Journal of Neurology
Description:
Neuromyelitis optica (NMO) and associated NMO spectrum disorders (NMOSDs) are neuroinflammatory diseases that frequently result in severe neurological disabilities. The aim of this study was to explore additional treatment options for NMO/NMOSD patients who are seropositive for anti-aquaporin 4 (AQP4) antibodies. We retrospectively evaluated the efficacy of immunosuppressants for NMO/NMOSDs by reviewing the clinical records of 52 patients confirmed as seropositive for anti-AQP4 antibodies. Of the 52 patients, 26 (23 women, three men) had received at least one kind of immunosuppressant other than corticosteroids. After eliminating ineligible cases, we evaluated the following 24 treatments in 22 patients (20 women, two men) that used azathioprine (AZA) (n = 9), cyclophosphamide (n = 1), cyclosporine A (CyA) (n = 9), tacrolimus (n = 2), methotrexate (n = 1), and mizoribine (n = 2). Both AZA and CyA treatments allowed us to decrease the median dose of the coadministered prednisone without affecting the expanded disability severity scale scores. In patients with relapsing-remitting courses, the annual relapse rate decreased from 1.7 (1.2–2.7) to 0.47 (0.36–0.59) after AZA treatments (n = 6, P = 0.028), and also showed a significant decrease from 2.7 (1.8–4.3) to 0.38 (0–0.97) after CyA treatment (n = 8, P = 0.012). These results indicate that CyA as well as AZA may help stabilize the disease activity in NMO/NMOSD patients seropositive for anti-AQP4 antibodies. This is the first case series study demonstrating the efficacy of CyA for the treatment of NMO/NMOSDs.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Science
Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,626,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We find it hard to spot revenue streams.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

article, pubmed, google, scholar, neuromyelitis, optica, cas, patients, neurol, neurology, treatment, cyclosporine, japan, corticosteroids, access, department, privacy, cookies, content, analysis, journal, spectrum, antiaquaporin, antibodies, efficacy, cya, therapy, lucchinetti, arch, data, publish, research, search, combination, kageyama, komori, takahashi, aza, pittock, weinshenker, multiple, sclerosis, antibody, aquaporin, university, school, information, log, october, takashi,

Topics {✒️}

month download article/chapter acute/subacute interstitial pneumonia increased t-cell immunity measuring anti-aqp4 antibodies related subjects wingerchuk dm full article pdf nmo spectrum disorders enhanced il-6 production privacy choices/manage cookies anti-aquaporin 4 seropositivity calcineurin inhibitors affect idiopathic nephrotic syndrome recurrent neuromyelitis optica early neuromyelitis optica anti-aqp4 antibodies systemic lupus erythematosus cytokine-producing mature nmo/nmosd patients seropositive aquaporin-4 water channel article kageyama relapsing-remitting courses amorin de souza angeles de cos relapsing transverse myelitis neuromyelitis optica treatment eliminating ineligible cases oliveira dm long-term follow revised diagnostic criteria rating neurologic impairment curve estimation immediately chest hrct findings opticospinal multiple sclerosis dr toshiyuki takahashi dr takuya matsushita conditions privacy policy check access instant access european economic area severe neurological disabilities long-term management kinki university school article journal repeated therapy anti-aquaporin 4 accepting optional cookies cyclosporine therapy takashi kageyama toshihiko suenaga

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica
         description:Neuromyelitis optica (NMO) and associated NMO spectrum disorders (NMOSDs) are neuroinflammatory diseases that frequently result in severe neurological disabilities. The aim of this study was to explore additional treatment options for NMO/NMOSD patients who are seropositive for anti-aquaporin 4 (AQP4) antibodies. We retrospectively evaluated the efficacy of immunosuppressants for NMO/NMOSDs by reviewing the clinical records of 52 patients confirmed as seropositive for anti-AQP4 antibodies. Of the 52 patients, 26 (23 women, three men) had received at least one kind of immunosuppressant other than corticosteroids. After eliminating ineligible cases, we evaluated the following 24 treatments in 22 patients (20 women, two men) that used azathioprine (AZA) (n = 9), cyclophosphamide (n = 1), cyclosporine A (CyA) (n = 9), tacrolimus (n = 2), methotrexate (n = 1), and mizoribine (n = 2). Both AZA and CyA treatments allowed us to decrease the median dose of the coadministered prednisone without affecting the expanded disability severity scale scores. In patients with relapsing-remitting courses, the annual relapse rate decreased from 1.7 (1.2–2.7) to 0.47 (0.36–0.59) after AZA treatments (n = 6, P = 0.028), and also showed a significant decrease from 2.7 (1.8–4.3) to 0.38 (0–0.97) after CyA treatment (n = 8, P = 0.012). These results indicate that CyA as well as AZA may help stabilize the disease activity in NMO/NMOSD patients seropositive for anti-AQP4 antibodies. This is the first case series study demonstrating the efficacy of CyA for the treatment of NMO/NMOSDs.
         datePublished:2012-10-18T00:00:00Z
         dateModified:2012-10-18T00:00:00Z
         pageStart:627
         pageEnd:634
         sameAs:https://doi.org/10.1007/s00415-012-6692-2
         keywords:
            Cyclosporine A
            Neuromyelitis optica
            Azathioprine
            Anti-aquaporin 4 antibody
            Neurology
            Neurosciences
            Neuroradiology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00415-012-6692-2/MediaObjects/415_2012_6692_Fig1_HTML.gif
         isPartOf:
            name:Journal of Neurology
            issn:
               1432-1459
               0340-5354
            volumeNumber:260
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Takashi Kageyama
               affiliation:
                     name:Tenri Hospital
                     address:
                        name:Department of Neurology, Tenri Hospital, Tenri, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Mika Komori
               affiliation:
                     name:Kyoto University
                     address:
                        name:Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Katsuichi Miyamoto
               affiliation:
                     name:Kinki University School of Medicine
                     address:
                        name:Department of Neurology, Kinki University School of Medicine, Osaka, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Akihiko Ozaki
               affiliation:
                     name:Kitano Hospital
                     address:
                        name:Department of Neurology, Kitano Hospital, Osaka, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Toshihiko Suenaga
               affiliation:
                     name:Tenri Hospital
                     address:
                        name:Department of Neurology, Tenri Hospital, Tenri, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ryosuke Takahashi
               affiliation:
                     name:Kyoto University
                     address:
                        name:Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Susumu Kusunoki
               affiliation:
                     name:Kinki University School of Medicine
                     address:
                        name:Department of Neurology, Kinki University School of Medicine, Osaka, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sadayuki Matsumoto
               affiliation:
                     name:Kitano Hospital
                     address:
                        name:Department of Neurology, Kitano Hospital, Osaka, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Takayuki Kondo
               affiliation:
                     name:Kitano Hospital
                     address:
                        name:Department of Neurology, Kitano Hospital, Osaka, Japan
                        type:PostalAddress
                     type:Organization
                     name:Takeda Hospital
                     address:
                        name:Center of Neuroimmunology, Takeda Hospital, Kyoto, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica
      description:Neuromyelitis optica (NMO) and associated NMO spectrum disorders (NMOSDs) are neuroinflammatory diseases that frequently result in severe neurological disabilities. The aim of this study was to explore additional treatment options for NMO/NMOSD patients who are seropositive for anti-aquaporin 4 (AQP4) antibodies. We retrospectively evaluated the efficacy of immunosuppressants for NMO/NMOSDs by reviewing the clinical records of 52 patients confirmed as seropositive for anti-AQP4 antibodies. Of the 52 patients, 26 (23 women, three men) had received at least one kind of immunosuppressant other than corticosteroids. After eliminating ineligible cases, we evaluated the following 24 treatments in 22 patients (20 women, two men) that used azathioprine (AZA) (n = 9), cyclophosphamide (n = 1), cyclosporine A (CyA) (n = 9), tacrolimus (n = 2), methotrexate (n = 1), and mizoribine (n = 2). Both AZA and CyA treatments allowed us to decrease the median dose of the coadministered prednisone without affecting the expanded disability severity scale scores. In patients with relapsing-remitting courses, the annual relapse rate decreased from 1.7 (1.2–2.7) to 0.47 (0.36–0.59) after AZA treatments (n = 6, P = 0.028), and also showed a significant decrease from 2.7 (1.8–4.3) to 0.38 (0–0.97) after CyA treatment (n = 8, P = 0.012). These results indicate that CyA as well as AZA may help stabilize the disease activity in NMO/NMOSD patients seropositive for anti-AQP4 antibodies. This is the first case series study demonstrating the efficacy of CyA for the treatment of NMO/NMOSDs.
      datePublished:2012-10-18T00:00:00Z
      dateModified:2012-10-18T00:00:00Z
      pageStart:627
      pageEnd:634
      sameAs:https://doi.org/10.1007/s00415-012-6692-2
      keywords:
         Cyclosporine A
         Neuromyelitis optica
         Azathioprine
         Anti-aquaporin 4 antibody
         Neurology
         Neurosciences
         Neuroradiology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00415-012-6692-2/MediaObjects/415_2012_6692_Fig1_HTML.gif
      isPartOf:
         name:Journal of Neurology
         issn:
            1432-1459
            0340-5354
         volumeNumber:260
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Takashi Kageyama
            affiliation:
                  name:Tenri Hospital
                  address:
                     name:Department of Neurology, Tenri Hospital, Tenri, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Mika Komori
            affiliation:
                  name:Kyoto University
                  address:
                     name:Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Katsuichi Miyamoto
            affiliation:
                  name:Kinki University School of Medicine
                  address:
                     name:Department of Neurology, Kinki University School of Medicine, Osaka, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Akihiko Ozaki
            affiliation:
                  name:Kitano Hospital
                  address:
                     name:Department of Neurology, Kitano Hospital, Osaka, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Toshihiko Suenaga
            affiliation:
                  name:Tenri Hospital
                  address:
                     name:Department of Neurology, Tenri Hospital, Tenri, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ryosuke Takahashi
            affiliation:
                  name:Kyoto University
                  address:
                     name:Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Susumu Kusunoki
            affiliation:
                  name:Kinki University School of Medicine
                  address:
                     name:Department of Neurology, Kinki University School of Medicine, Osaka, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sadayuki Matsumoto
            affiliation:
                  name:Kitano Hospital
                  address:
                     name:Department of Neurology, Kitano Hospital, Osaka, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Takayuki Kondo
            affiliation:
                  name:Kitano Hospital
                  address:
                     name:Department of Neurology, Kitano Hospital, Osaka, Japan
                     type:PostalAddress
                  type:Organization
                  name:Takeda Hospital
                  address:
                     name:Center of Neuroimmunology, Takeda Hospital, Kyoto, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Neurology
      issn:
         1432-1459
         0340-5354
      volumeNumber:260
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Tenri Hospital
      address:
         name:Department of Neurology, Tenri Hospital, Tenri, Japan
         type:PostalAddress
      name:Kyoto University
      address:
         name:Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
         type:PostalAddress
      name:Kinki University School of Medicine
      address:
         name:Department of Neurology, Kinki University School of Medicine, Osaka, Japan
         type:PostalAddress
      name:Kitano Hospital
      address:
         name:Department of Neurology, Kitano Hospital, Osaka, Japan
         type:PostalAddress
      name:Tenri Hospital
      address:
         name:Department of Neurology, Tenri Hospital, Tenri, Japan
         type:PostalAddress
      name:Kyoto University
      address:
         name:Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
         type:PostalAddress
      name:Kinki University School of Medicine
      address:
         name:Department of Neurology, Kinki University School of Medicine, Osaka, Japan
         type:PostalAddress
      name:Kitano Hospital
      address:
         name:Department of Neurology, Kitano Hospital, Osaka, Japan
         type:PostalAddress
      name:Kitano Hospital
      address:
         name:Department of Neurology, Kitano Hospital, Osaka, Japan
         type:PostalAddress
      name:Takeda Hospital
      address:
         name:Center of Neuroimmunology, Takeda Hospital, Kyoto, Japan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Takashi Kageyama
      affiliation:
            name:Tenri Hospital
            address:
               name:Department of Neurology, Tenri Hospital, Tenri, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Mika Komori
      affiliation:
            name:Kyoto University
            address:
               name:Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Katsuichi Miyamoto
      affiliation:
            name:Kinki University School of Medicine
            address:
               name:Department of Neurology, Kinki University School of Medicine, Osaka, Japan
               type:PostalAddress
            type:Organization
      name:Akihiko Ozaki
      affiliation:
            name:Kitano Hospital
            address:
               name:Department of Neurology, Kitano Hospital, Osaka, Japan
               type:PostalAddress
            type:Organization
      name:Toshihiko Suenaga
      affiliation:
            name:Tenri Hospital
            address:
               name:Department of Neurology, Tenri Hospital, Tenri, Japan
               type:PostalAddress
            type:Organization
      name:Ryosuke Takahashi
      affiliation:
            name:Kyoto University
            address:
               name:Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
               type:PostalAddress
            type:Organization
      name:Susumu Kusunoki
      affiliation:
            name:Kinki University School of Medicine
            address:
               name:Department of Neurology, Kinki University School of Medicine, Osaka, Japan
               type:PostalAddress
            type:Organization
      name:Sadayuki Matsumoto
      affiliation:
            name:Kitano Hospital
            address:
               name:Department of Neurology, Kitano Hospital, Osaka, Japan
               type:PostalAddress
            type:Organization
      name:Takayuki Kondo
      affiliation:
            name:Kitano Hospital
            address:
               name:Department of Neurology, Kitano Hospital, Osaka, Japan
               type:PostalAddress
            type:Organization
            name:Takeda Hospital
            address:
               name:Center of Neuroimmunology, Takeda Hospital, Kyoto, Japan
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Neurology, Tenri Hospital, Tenri, Japan
      name:Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
      name:Department of Neurology, Kinki University School of Medicine, Osaka, Japan
      name:Department of Neurology, Kitano Hospital, Osaka, Japan
      name:Department of Neurology, Tenri Hospital, Tenri, Japan
      name:Department of Neurology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
      name:Department of Neurology, Kinki University School of Medicine, Osaka, Japan
      name:Department of Neurology, Kitano Hospital, Osaka, Japan
      name:Department of Neurology, Kitano Hospital, Osaka, Japan
      name:Center of Neuroimmunology, Takeda Hospital, Kyoto, Japan
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(143)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.75s.

LINK . SPRINGER . COM {}